My Favorite Biotech | The Motley Fool
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
Source: fool.com
Stay updated with breaking news from Patrick Bafuma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
Here's why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
In the healthcare markets, much time and energy have been focused on COVID-19. But there are some amazing opportunities outside the COVID space.
Will either of these hopeful vaccine makers continue to thrash the market?
After a hot start, the stock has recently lagged the market. Is now a good time to buy?